Abstract:BackgroundThe Chinese Government has announced plans to reform provider-payment methods at public hospitals by moving from fee-for-service to prospective and aggregated methods including diagnosis-related groups (DRG) to control health expenditures. In 2012, Beijing pioneered China's first DRG payment system in six hospitals. The aim of this study was to explore the effectiveness of Beijing's DRG pilot reform in reducing expenditures, out-of-pocket payments, and potential behaviors to circumvent payment control, including readmissions, selection, and cost-shifting.MethodsWe obtained discharge data from the Beijing Health Insurance Bureau for the period January, 2010, to September, 2012, from 14 tertiary general hospitals, which included six hospitals piloting DRGs within a portion of their payment system and eight control hospitals that implemented purely fee-for-service-based payment. Using a differences-in-differences design, we used hospital discharge data to assess the pilot's impact on cost containment. We did regression analyses to assess associations of DRG payment with outcome variables of health expenditures, length-of-stay, and out-of-pocket payment. The study was approved by Peking University Committee for Biomedical Researches.FindingsPost-reform, there were 36 780 cases using DRG payments and 50 322 cases in the control hospitals paid through fee-for-service. Our findings showed that DRG payment led to ¥1251 (6·2%) reductions in health expenditure and ¥647 (10·5%) reductions in out-of-pocket payment per admission. Length of stay or cost-shifting did not differ between DRG and non-DRG cases. Readmission rates were reduced (–1·4%) with DRG payment relative to non-DRG. About 19 814 (35%) potential DRG cases, however, were reverted back to fee-for-service-based payment. Hospitals processed the payment of older patients with more complications through fee-for-service payment, circumventing the effectiveness of payment reform.InterpretationFor China and other low-income and middle-income countries to fully implement prospective payment systems, such as DRG payments, without allowing circumvention seen in a partially implemented system, it might first be necessary to strengthen core monitoring and technological systems that would support feasibility of DRG payments. Continuous evidence-based monitoring and assessment, partnered with adequate management systems, are necessary to enable these countries to broadly implement DRGs and refine payment systems.FundingChina Medical Board (grant number CMB-OC-12-120).

Invesitigation on Pilot Medical Fees in Public Hospitals in Beijing City

The Impact of a Pilot Reform on the Diagnosis-Related-groups Payment System in China: a Difference-in-difference Study

Payment Reform Pilot in Beijing Hospitals Reduced Expenditures and Out-Of-Pocket Payments Per Admission.

Control Costs, Enhance Quality, and Increase Revenue in Three Top General Public Hospitals in Beijing, China

Survey on Satisfaction of Inpatients in Pilot Public Hospital of Reform in Beijing

Study on Charging Level of Pharmaceutical Service Fee in China

The Impact of Separating Drug and Medical Service on the Hospitalization Expense of Patients with Medical Insurance in Pilot Hospitals of Beijing

Effect of separating drug sales from medical services on hospital revenue and medical services in the county public hospitals of Guangxi Province

Influence of Medical Service Charge on Doctors' Remuneration and Work

Analysis of Fee and Amount-of-Service on Newly Built Public Hospitals in Suburbs in Shanghai

Impacts of Price Changes on Public Hospital Reforms in China: Evidence from 25 Million Patients at Tertiary Hospitals.

Investigation on Satisfaction of Outpatients on Policy of Separation of Clinical from Pharmacy from 4 Hospi-tals of Health Reform Pilots in Shanghai

The impact of separating drug sales from medical services reform on mechanism of controlling outpatient and emergency expenses in Beijing

Short-term and long-term unintended impacts of a pilot reform on Beijing’s zero markup drug policy: a propensity score-matched study

Short-term and Long-Term Unintended Impacts of a Pilot Reform on Beijing's Zero Markup Drug Policy: a Propensity Score-Matched Study

Impact of China's Healthcare Price Reforms on Traditional Chinese Medicine Public Hospitals in Beijing: an Interrupted Time-Series Study

A feasibility study on the implementation of dispensing fee in China

Small Money, Big Change: the Distributional Impact of Differentiated Doctor's Visit Fee on Healthcare Utilization.

Effects of Chinese medical pricing reform on the structure of hospital revenue and healthcare expenditure in county hospital: an interrupted time series analysis

The Situation and Effectiveness Analysis of the Pilot Implement of Diagnosis Related Groups Payment in Beijing

INVESTIGATION AND ANALYSIS OF THE AFFECT OF CANCELLING DRUG ADDITION ON PUBLIC HOSPITALS